The Role of R&D in Cancer Research

Oncology meeting in Chicago attracts 42,000 people every year for at least the last 10 years and beyond. It has to be only one of several places that's big enough because you can do hematology meeting but not oncology. R&D isn't proportionate to burden of disease; it's proportionate to net expected outcome. This is the story that I think everyone in oncology wishes we were chasing," says Dr. John Anderson.